Table: Torii Pharmaceutical - 9-MTH parent results
Oct 30 (Reuters)-
Torii Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2020 Sep 30, 2019 Dec 31, 2020
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 30.17 31.32 41.00
(-3.7 pct) (-31.2 pct) (-4.6 pct)
Operating 3.55 662 mln 4.20
(+436.5 pct) (-78.2 pct) (+193.6 pct)
Recurring 3.75 839 mln 4.50
(+346.9 pct) (-73.2 pct) (+166.0 pct)
Net 2.51 26.47 3.10
(-90.5 pct) (-88.7 pct)
EPS 89.34 yen 942.93 yen 110.40 yen
EPS Diluted 89.33 yen
Ann Div 48.00 yen 48.00 yen
-Q2 div 24.00 yen 24.00 yen
-Q4 div 24.00 yen 24.00 yen
NOTE - Torii Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4551.T
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)